<DOC>
	<DOCNO>NCT02910284</DOCNO>
	<brief_summary>This study follow-up study Study GEN-003-002 evaluate long-term efficacy immunogenicity GEN-003 subject genital HSV-2 infection .</brief_summary>
	<brief_title>Long-term Follow-up GEN-003-002 Subjects Efficacy Immunogenicity</brief_title>
	<detailed_description />
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Herpes Genitalis</mesh_term>
	<criteria>1 . Completion Study GEN003002 2 . Receipt least 1 dose GEN003 ( dose combination ) Study GEN003002 . 3 . Collection least 45 56 anogenital swabs Month 11 12 swab collection period Study GEN003002 . 4 . Willing able provide write informed consent . 5 . Willing perform comply study procedure , include attend clinic visit schedule . 6 . For swab collection period , willing use HSV2 antiviral therapy 14 day swab collection period end period . 1 . Any important protocol deviation Study GEN003002 . 2 . Use HSV2 antiviral therapy within 14 day begin Swab Collection Period 1 . 3 . Use topical steroid antiviral medication anogenital region within 14 day begin Swab Collection Period 1 . 4 . Use tenofovir , lysine , medication supplement know purported affect HSV outbreak frequency intensity within 14 day begin Swab Collection Period 1 . 5 . Immunocompromised individual , include receive immunosuppressive dos corticosteroid ( 20 mg prednisone give daily alternative day 2 week within 6 month Visit 1 , dose corticosteroid within 30 day Visit 1 , highdose inhaled corticosteroid [ &gt; 960 Âµg/day beclomethasone diproprionate equivalent ] ) immunosuppressive agent . 6 . Presence history autoimmune disease , regardless current treatment . 7 . Receipt vaccine contain HSV2 antigens GEN003 . 8 . Pregnant woman . 9 . History drug alcohol abuse , opinion Investigator , would interfere patient 's ability comply requirement study . 10 . Onset AESI since Month 12 study GEN003002 . 11 . Other active , uncontrolled comorbidities , opinion Investigator , would make subject unsuitable study unable comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HSV</keyword>
	<keyword>Herpes</keyword>
	<keyword>Genital Herpes</keyword>
</DOC>